← FDA Drug Approvals (Drugs@FDA)
AMPHOTERICIN B
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: EUGIA PHARMA · Approved 2022-11-17
Drug application
- FDA Application #
ANDA214010- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- AMPHOTERICIN B
- Generic name
- AMPHOTERICIN B
- Active ingredients
- AMPHOTERICIN B
- Dosage form
- INJECTABLE, LIPOSOMAL
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- EUGIA PHARMA
- Manufacturer
- Eugia US LLC
- First approval
- 2022-11-17
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown